All Phenotypes Scrib<tm1.1Phum> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Scrib^tm1.1Phum
targeted mutation 1.1, Patrick O Humbert
MGI:5299425

Summary

5 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib^tm1.1Phum	involves: 129S4/SvJae	MGI:5638045
cn2	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib⁺	involves: 129S4/SvJae	MGI:5638047
cn3	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib^tm1.1Phum Tg(Pbsn-cre)20Fwan/0	involves: 129S4/SvJae * FVB/NCrl	MGI:5300204
cn4	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib⁺ Tg(Pbsn-cre)20Fwan/0	involves: 129S4/SvJae * FVB/NCrl	MGI:5300205
cn5	Scrib^tm1.1Phum/Scrib^tm1.1Phum Tg(Pbsn-cre)20Fwan/0	involves: FVB/NCrl	MGI:5300202

Allelic Composition	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib^tm1.1Phum
Genetic Background	involves: 129S4/SvJae

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Kras^tm4Tyj mutation (9 available); any Kras mutation (76 available)
Scrib^tm1.1Phum mutation (0 available); any Scrib mutation (53 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased lung tumor incidence ( J:216266 )

• 100% of mice develop lung lesions at 6 weeks post intranasal adenoviral cre (AdCre) administration, ranging from grades 1 to 3

• mice show accelerated lung tumorigenesis, with more advanced and higher-grade tumors post intranasal AdCre administration compared to single Kras heterozygotes

• a 2.9-fold increase in tumor burden compared to single Kras heterozygotes at 12 weeks post intranasal AdCre administration

• lung tumors from intranasally AdCre treated mice show enhanced stromal reactivity and inflammation

respiratory system

increased lung tumor incidence ( J:216266 )

• 100% of mice develop lung lesions at 6 weeks post intranasal adenoviral cre (AdCre) administration, ranging from grades 1 to 3

• mice show accelerated lung tumorigenesis, with more advanced and higher-grade tumors post intranasal AdCre administration compared to single Kras heterozygotes

• a 2.9-fold increase in tumor burden compared to single Kras heterozygotes at 12 weeks post intranasal AdCre administration

• lung tumors from intranasally AdCre treated mice show enhanced stromal reactivity and inflammation

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
lung cancer		DOID:1324	OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210	J:216266

Allelic Composition	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib⁺
Genetic Background	involves: 129S4/SvJae

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased lung tumor incidence ( J:216266 )

• 83% of mice develop tumors ranging from grades 1 to 3 at 6 weeks post intranasal adenoviral cre (AdCre) administration

respiratory system

increased lung tumor incidence ( J:216266 )

• 83% of mice develop tumors ranging from grades 1 to 3 at 6 weeks post intranasal adenoviral cre (AdCre) administration

lung epithelium hyperplasia ( J:216266 )

• 100% of mice show epithelial hyperplasia at 6 weeks post intranasal AdCre administration

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
lung cancer		DOID:1324	OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210	J:216266

Allelic Composition	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib^tm1.1Phum Tg(Pbsn-cre)20Fwan/0
Genetic Background	involves: 129S4/SvJae * FVB/NCrl

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:178461 )

• 3 of 10 mice exhibit signs of illness and were sacrificed prior to 400 days

reproductive system

prostate gland hyperplasia ( J:178461 )

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 20% of mice

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 33% of mice

abnormal prostate gland physiology ( J:178461 )

• increased cell proliferation and apoptosis compared to in Tg(Pbsn-cre)20Fwan mice

neoplasm

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 33% of mice

increased carcinoma incidence ( J:178461 )

• 3 of 15 mice develop poorly differentiated invasive carcinoma

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 20% of mice

digestive/alimentary system

abnormal intestine morphology ( J:178461 )

• focal intestinal metaplasia

endocrine/exocrine glands

prostate gland hyperplasia ( J:178461 )

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 20% of mice

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 33% of mice

abnormal prostate gland physiology ( J:178461 )

• increased cell proliferation and apoptosis compared to in Tg(Pbsn-cre)20Fwan mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
prostate cancer		DOID:10283	OMIM:176807 OMIM:300147 OMIM:300704 OMIM:601518 OMIM:602759 OMIM:608656 OMIM:608658 OMIM:609299 OMIM:609558 OMIM:610321 OMIM:610997 OMIM:611100 OMIM:611868 OMIM:611928 OMIM:611955 OMIM:611958 OMIM:611959	J:178461

Allelic Composition	Kras^tm4Tyj/Kras⁺ Scrib^tm1.1Phum/Scrib⁺ Tg(Pbsn-cre)20Fwan/0
Genetic Background	involves: 129S4/SvJae * FVB/NCrl

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 13% of mice

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 20% of mice

abnormal prostate gland physiology ( J:178461 )

• increased cell proliferation and apoptosis compared to in Tg(Pbsn-cre)20Fwan mice

neoplasm

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 13% of mice

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 20% of mice

digestive/alimentary system

abnormal intestine morphology ( J:178461 )

• focal intestinal metaplasia

endocrine/exocrine glands

increased prostate gland adenocarcinoma incidence ( J:178461 )

• well-differentiated adenocarcinomas in 13% of mice

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• high-grade in 20% of mice

abnormal prostate gland physiology ( J:178461 )

• increased cell proliferation and apoptosis compared to in Tg(Pbsn-cre)20Fwan mice

Allelic Composition	Scrib^tm1.1Phum/Scrib^tm1.1Phum Tg(Pbsn-cre)20Fwan/0
Genetic Background	involves: FVB/NCrl

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Scrib^tm1.1Phum mutation (0 available); any Scrib mutation (53 available)
Tg(Pbsn-cre)20Fwan mutation (1 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

prostate gland hyperplasia ( J:178461 )

• 88% at 100 days, 75% at 200 days, and 90% at 400 days

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• low-grade

abnormal prostate gland physiology ( J:178461 )

• increase in cell proliferation compared with control

neoplasm

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• low-grade

endocrine/exocrine glands

prostate gland hyperplasia ( J:178461 )

• 88% at 100 days, 75% at 200 days, and 90% at 400 days

increased prostate intraepithelial neoplasia incidence ( J:178461 )

• low-grade

abnormal prostate gland physiology ( J:178461 )

• increase in cell proliferation compared with control

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23